Stark, Felicity C.
Akache, Bassel
Deschatelets, Lise
Tran, Anh
Stuible, Matthew
Durocher, Yves
McCluskie, Michael J.
Agbayani, Gerard
Dudani, Renu
Harrison, Blair A.
Renner, Tyler M.
Makinen, Shawn R.
Bavananthasivam, Jegarubee
Duque, Diana
Gagne, Martin
Zimmermann, Joseph
Zarley, C. David
Cochrane, Terrence R.
Handfield, Martin
Article History
Received: 2 March 2022
Accepted: 27 May 2022
First Online: 13 June 2022
Competing interests
: CDZ, TRC and MH declare a potential conflict of interest as per their employment/contract relationships with Oragenics. CDZ owns Oragenics stock options, and MH owns Oragenics stock and options. JZ declares a potential conflict of interest as a shareholder in Inspirevax who own commercial rights to BDX301. All other authors declare no competing interests.